Technology News and Research

RSS

NCI Re-Ups Biomarker Strategies’ SBIR Award For Melanoma Cdx

BioMarker Strategies received a $1.5 million SBIR award to develop a pathway-based companion diagnostic test to facilitate the selection of optimal therapy for patients with melanoma. This award was preceded by an NCI award of $200,000 almost two years ago in September 2011.

25 Sep 2013

VeriMed secures $3 million in venture funding

VeriMed, a technology company that works to provide a secure, transparent and safe supply chain for controlled substances, today announced it has secured $3 million in venture funding. The financing was led by Fortis Capital Holdings, a private investment firm.

25 Sep 2013

Soligenix awarded $6.4M contract to advance preclinical development of OrbeShield for GI ARS

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).

25 Sep 2013

Research finds no increased risks of mortality for early-stage breast cancer patients receiving XRT

Early-stage breast cancer patients who receive external beam therapy (XRT) are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies, according to research presented today at the American Society for Radiation Oncology's 55th Annual Meeting.

25 Sep 2013

FM market for healthcare in Australia expected to grow at annual rate of 3.1%, finds new analysis

In 2012, the public healthcare sector in Australia was more than twice the size of the private healthcare sector in terms of hospital beds and total hospital expenditure. While private healthcare and other small to medium medical facilities do provide facilities management opportunities, it is mostly to small and medium FM companies. The larger and well-established FM providers will mostly come into play with the successful implementation of public private partnerships model in the healthcare sector.

25 Sep 2013

Simple smartphone fundus photography could help detect eye disease

Retinal (or fundus) photography is an essential part of any ophthalmology practice. Commercial fundus cameras can cost tens to hundreds of thousands of dollars, making the technology out of reach for smaller ophthalmic practices and to physicians in third-world countries.

25 Sep 2013

Use of insulin pump with sensor reduces rate of severe hypoglycemia

Use of an insulin pump with a sensor that suspends insulin delivery when blood glucose falls below a set threshold reduced the rate of severe and moderate hypoglycemia among patients with type 1 diabetes and impaired awareness of hypoglycemia, according to a study in the September 25 issue of JAMA.

25 Sep 2013

Microbial clock: New tool to determine time of death

An intriguing study led by the University of Colorado Boulder may provide a powerful new tool in the quiver of forensic scientists attempting to determine the time of death in cases involving human corpses: a microbial clock.

25 Sep 2013

inVentiv Health Clinical releases new tool to connect physicians participating in late-stage research

inVentiv Health Clinical, a leading global supplier of drug development services, today announced the launch of an innovative, web-based network to efficiently connect physicians interested in participating in late-stage research to appropriate clinical trials.

24 Sep 2013

Red River partners with Firetide to launch new healthcare IT division

New Hampshire-based Red River, a leading information technology services provider, announced a partnership today between Red River Healthcare and Firetide, a provider of wireless infrastructures that enable multimedia services for federal and commercial customers, as part of the launch of Red River's new healthcare IT division.

24 Sep 2013

Pancreatic Cancer Imaging Agent Earns Mabvax $1.75M SBIR Award

...

24 Sep 2013

NCI Funds Development Of Chrysalis’ Brain Tissue Damage Treatment

The National Cancer Institute awarded Chrysalis BioTherapeutics a $1.5 million contract to continue development of Chrysalin® to mitigate radiotherapy-induced damage to normal brain tissue. The project is a collaboration between Chrysalis, Baylor College of Medicine, and the University of Texas Medical Branch (UTMB).

24 Sep 2013

First Direct Measurement Of Spinal Cord Myelin In MS

...

24 Sep 2013

Astrazeneca Licenses 3 X-Chem Drug Discovery Programs

...

24 Sep 2013

Abbvie, Galapagos Ink Up To $405M CF Collaboration

...

24 Sep 2013

New And Improved Method For Analyzing Single-Cell Gene Expression

...

24 Sep 2013

New laser provides better treatment for eye diseases in diabetes patients

A new laser is helping experts at the Truhlsen Eye Institute at the University of Nebraska Medical Center provide better treatment for eye diseases. This advanced laser can prevent blindness for some patients with serious conditions.

24 Sep 2013

MLOZ to manage health insurance portfolio with Sapiens IDIT Software Suite

Sapiens International Corporation, a global provider of innovative software solutions for the financial services industry, announced today that MLOZ, the National Federation of Independent Health Insurance Funds, offering services to more than 18% of the Belgian population, has selected Sapiens IDIT Software Suite, to manage its health insurance portfolio, in a multimillion dollar deal.

24 Sep 2013

New ultra-stretchable OLED could lead to foldable screens for new smartphones

Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material.

24 Sep 2013

Lung cancer patients who received IMRT report less decline in their QOL

An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013